Bemnifosbuvir (BEM)

Drug identity checked against registry records

Also recorded as AT-527

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19NCT05629962AVIRPhase 3Completed2024-04-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.